• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diabetes, insulin use, and cancer risk: are observational studies part of the solution-or part of the problem?

作者信息

Johnson Jeffrey A, Gale Edwin A M

机构信息

School of Public Health, University of Alberta, Edmonton, Canada.

出版信息

Diabetes. 2010 May;59(5):1129-31. doi: 10.2337/db10-0334.

DOI:10.2337/db10-0334
PMID:20427699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2857892/
Abstract
摘要

相似文献

1
Diabetes, insulin use, and cancer risk: are observational studies part of the solution-or part of the problem?糖尿病、胰岛素使用与癌症风险：观察性研究是解决方案的一部分还是问题的一部分？
Diabetes. 2010 May;59(5):1129-31. doi: 10.2337/db10-0334.
2
Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.2 型糖尿病患者高血糖和胰岛素使用与癌症风险的相关性：香港糖尿病注册研究。
Diabetes. 2010 May;59(5):1254-60. doi: 10.2337/db09-1371. Epub 2010 Feb 25.
3
Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260.评论：杨等人（2010年）。2型糖尿病患者高血糖和胰岛素使用与癌症风险的关联：香港糖尿病登记处。《糖尿病》；59:1254 - 1260。
Diabetes. 2010 Sep;59(9):e17-8; author reply e19-22. doi: 10.2337/db10-0777.
4
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter].接受人胰岛素或胰岛素类似物治疗的糖尿病患者发生恶性肿瘤的风险。对纳格尔·J·M、曼斯曼·U、韦格谢德·K等人[信件]及西蒙·D[信件]的回复。
Diabetologia. 2010 Jan;53(1):209-11. doi: 10.1007/s00125-009-1582-6. Epub 2009 Oct 24.
5
Insulin glargine (Lantus) and cancer risk.甘精胰岛素（来得时）与癌症风险。
Med Lett Drugs Ther. 2009 Aug 24;51(1319):67-8.
6
Managing hyperglycaemia in patients with type 2 diabetes and known cardiovascular disease.2型糖尿病合并已知心血管疾病患者的高血糖管理。
J R Soc Med. 2012 Jan;105(1):2-4. doi: 10.1258/jrsm.2011.110162.
7
Type 2 diabetes mellitus and risk of malignancy: is there a strategy to identify a subphenotype of patients with increased susceptibility to endogenous and exogenous hyperinsulinism?2 型糖尿病与恶性肿瘤风险：是否存在一种策略来识别内源性和外源性高胰岛素血症易感性增加的患者亚表型？
Diabet Med. 2011 Mar;28(3):276-86. doi: 10.1111/j.1464-5491.2010.03132.x.
8
Management of Inpatient Hyperglycemia and Diabetes in Older Adults.老年人住院患者高血糖和糖尿病的管理。
Clin Geriatr Med. 2020 Aug;36(3):491-511. doi: 10.1016/j.cger.2020.04.008. Epub 2020 Apr 18.
9
Putting insulin glargine and malignancies into perspective.正确看待甘精胰岛素与恶性肿瘤的关系。
Oncologist. 2009 Dec;14(12):1169-74. doi: 10.1634/theoncologist.2009-0206. Epub 2009 Dec 10.
10
[Hypoglycemic sulfamides: new pharmacologic data and practical implications].[降血糖磺酰胺类药物：新的药理学数据及实际意义]
Diabetes Metab. 1998 Jun;24(3):276-80.

引用本文的文献

1
Insulin resistance and cancer: molecular links and clinical perspectives.胰岛素抵抗与癌症：分子联系及临床展望
Mol Cell Biochem. 2025 Mar 15. doi: 10.1007/s11010-025-05245-8.
2
Minimizing Mitogenic Potency of Insulin Analogues Through Modification of a Disulfide Bond.通过修饰二硫键来降低胰岛素类似物的有丝分裂原活性。
Front Endocrinol (Lausanne). 2022 Jun 27;13:907864. doi: 10.3389/fendo.2022.907864. eCollection 2022.
3
Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.使用非甾体类抗炎药靶向癌症治疗中的经典 WNT/β-连环蛋白通路。
Cells. 2019 Jul 15;8(7):726. doi: 10.3390/cells8070726.
4
Consumption of Sugar-Sweetened Beverages Has a Dose-Dependent Effect on the Risk of Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Dose-Response Meta-Analysis.摄入含糖饮料与非酒精性脂肪性肝病风险呈剂量依赖性关系：一项更新的系统评价和剂量反应荟萃分析。
Int J Environ Res Public Health. 2019 Jun 21;16(12):2192. doi: 10.3390/ijerph16122192.
5
Activation of cancer-related and mitogen-activated protein kinase signaling pathways in human mature osteoblasts isolated from patients with type 2 diabetes.从2型糖尿病患者中分离出的人成熟成骨细胞中癌症相关和丝裂原活化蛋白激酶信号通路的激活。
Bone Rep. 2019 Feb 21;10:100199. doi: 10.1016/j.bonr.2019.100199. eCollection 2019 Jun.
6
Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis.糖饮料消费与非酒精性脂肪肝疾病的关联：系统评价和荟萃分析。
Eur J Nutr. 2019 Aug;58(5):1759-1769. doi: 10.1007/s00394-018-1711-4. Epub 2018 May 14.
7
Anti-Diabetic Drugs: Cure or Risk Factors for Cancer?抗糖尿病药物：是癌症的治愈方法还是风险因素？
Pathol Oncol Res. 2018 Oct;24(4):745-755. doi: 10.1007/s12253-018-0402-z. Epub 2018 Mar 13.
8
Favourable changes in mortality in people with diabetes: US NHANES 1999-2010.糖尿病患者死亡率的有利变化：美国 NHANES 1999-2010 年。
Diabetes Obes Metab. 2018 Jan;20(1):85-93. doi: 10.1111/dom.13039. Epub 2017 Jul 27.
9
Decreased Levels of Circulating Cancer-Associated Protein Biomarkers Following Bariatric Surgery.减肥手术后循环中癌症相关蛋白质生物标志物水平降低。
Obes Surg. 2017 Mar;27(3):578-585. doi: 10.1007/s11695-016-2321-y.
10
Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.二甲双胍的使用可提高糖尿病肝癌患者的生存率：系统评价与荟萃分析。
Oncotarget. 2016 Oct 4;7(40):66202-66211. doi: 10.18632/oncotarget.11033.

本文引用的文献

1
Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.2 型糖尿病患者高血糖和胰岛素使用与癌症风险的相关性：香港糖尿病注册研究。
Diabetes. 2010 May;59(5):1254-60. doi: 10.2337/db09-1371. Epub 2010 Feb 25.
2
Does insulin therapy promote, reduce, or have a neutral effect on cancers?胰岛素治疗对癌症有促进、减少还是中性作用？
JAMA. 2010 Feb 3;303(5):446-7. doi: 10.1001/jama.2010.60.
3
Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?胰高血糖素样肽-1疗法与外分泌胰腺：无辜旁观者还是友军误伤？
Diabetologia. 2010 Jan;53(1):1-6. doi: 10.1007/s00125-009-1591-5. Epub 2009 Nov 6.
4
Does diabetes therapy influence the risk of cancer?糖尿病治疗会影响患癌风险吗？
Diabetologia. 2009 Sep;52(9):1699-708. doi: 10.1007/s00125-009-1441-5.
5
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.降糖治疗对 2 型糖尿病患者癌症风险的影响。
Diabetologia. 2009 Sep;52(9):1766-77. doi: 10.1007/s00125-009-1440-6. Epub 2009 Jul 2.
6
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.罗格列酮用于2型糖尿病口服联合治疗的心血管结局评估（RECORD）：一项多中心、随机、开放标签试验
Lancet. 2009 Jun 20;373(9681):2125-35. doi: 10.1016/S0140-6736(09)60953-3. Epub 2009 Jun 6.
7
Glucose control and vascular complications in veterans with type 2 diabetes.2型糖尿病退伍军人的血糖控制与血管并发症
N Engl J Med. 2009 Jan 8;360(2):129-39. doi: 10.1056/NEJMoa0808431. Epub 2008 Dec 17.
8
Insulin and insulin-like growth factor signalling in neoplasia.肿瘤形成中的胰岛素及胰岛素样生长因子信号传导
Nat Rev Cancer. 2008 Dec;8(12):915-28. doi: 10.1038/nrc2536.
9
Effects of intensive glucose lowering in type 2 diabetes.强化降糖对2型糖尿病的影响。
N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.
10
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.2型糖尿病患者强化血糖控制与血管转归
N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.